EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Fertility outcomes in male adults with congenital hypogonadotropic hypogonadism treated during puberty with human chorionic gonadotropin and recombinant follicle stimulating hormone

Francisca Grob iD, Rachna Keshwani, Eleanor Angley, Margaret Zacharin

Journal of Paediatrics and Child Health · 2024

DOI: 10.1111/jpc.16540 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Paediatrics and Child Health, 2024. Verfasst von Francisca Grob und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The Royal Children's Hospital, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Chorionic Gonadotropin, Hypogonadism. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Hormone replacement therapy with testosterone for pubertal induction in boys with congenital hypogonadotropic hypogonadism (CHH) achieves virilization but not spermatogenesis. By contrast, human chorionic gonadotropin (hCG) and recombinant follicle stimulating hormone (rFSH) provides both virilization and spermatogenesis. Fertility outcomes of boys treated with recombinant therapy during adolescence have been infrequently described. We report fertility induction and pregnancy outcomes in CHH patients treated with recombinant gonadotropins during puberty.

Methods

Data of six subjects with CHH ( n = 3 Kallmann syndrome & n = 3 Isolated hypogonadotropic hypogonadism) treated with hCG and FSH for pubertal induction were reviewed. Of these, five underwent subsequent fertility induction while one desired fertility at the end of pubertal induction.

Results

Partners of all subjects achieved pregnancies using hCG and rFSH, all with full term live births. All infants were clinically normal.

Conclusion

This study provides early evidence of proof of concept of use of gonadotropin induction of puberty being beneficial in subsequent fertility outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chorionic GonadotropinHypogonadismAdultPregnancyInfantFemaleAdolescentHumansMaleFollicle Stimulating HormoneTestosteroneFertilityRecombinant ProteinsPubertyVirilism

Stichwörter der Autor:innen

Kallmann syndromefertilitygonadotropinhypogonadotropic hypogonadismpregnancy

Substanzen

Chorionic GonadotropinFollicle Stimulating HormoneTestosteroneRecombinant Proteins

Autor:innen und Institutionen

  • Department of Endocrinology, The Royal Children's Hospital, Melbourne, Victoria, Australia.
  • Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
  • Division of Paediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Department of Pediatrics, Surya Hospital, Mumbai, India.

ORCID-Profile: Francisca Grob

Zitieren

APA

Grob, F., Keshwani, R., Angley, E., & Zacharin, M. (2024). Fertility outcomes in male adults with congenital hypogonadotropic hypogonadism treated during puberty with human chorionic gonadotropin and recombinant follicle stimulating hormone. Journal of Paediatrics and Child Health. https://doi.org/10.1111/jpc.16540

Vancouver

Grob F, Keshwani R, Angley E, Zacharin M. Fertility outcomes in male adults with congenital hypogonadotropic hypogonadism treated during puberty with human chorionic gonadotropin and recombinant follicle stimulating hormone. Journal of Paediatrics and Child Health. 2024. doi:10.1111/jpc.16540

BibTeX
@article{Grob2024,
  author = {Grob, Francisca and Keshwani, Rachna and Angley, Eleanor and Zacharin, Margaret},
  title = {Fertility outcomes in male adults with congenital hypogonadotropic hypogonadism treated during puberty with human chorionic gonadotropin and recombinant follicle stimulating hormone},
  journal = {Journal of Paediatrics and Child Health},
  year = {2024},
  doi = {10.1111/jpc.16540}
}
Kostenlos starten →